Mereo BioPharma Group plc

Net Asset Value • Mar 6, 2020

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1953F

Mereo BioPharma Group plc

06 March 2020

Mereo BioPharma Group plc

Block Listing Interim Review

Pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for Companies, Mereo BioPharma Group plc makes the following update on its block listing:

Date: 6 March 2020

Name of applicant:		Mereo BioPharma Group plc
Name of scheme:		2015 Plan Mereo BioPharma Group plc Share Option Plan
Period of return:	From:	06/09/19	To:	06/03/20
Balance of unallotted securities under scheme(s) from previous return:		7,565,929
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		0
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):		0
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:		7,565,929

Name of contact:	Charles Sermon
Telephone number of contact:	+44 (0)333 023 7300

(Note: Italicised terms have the same meaning as given in the Listing Rules.)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

BLRKZGGFKKNGGZM